» Articles » PMID: 24370890

Lessons from the Heart: Mirroring Electrophysiological Characteristics During Cardiac Development to in Vitro Differentiation of Stem Cell Derived Cardiomyocytes

Overview
Date 2013 Dec 28
PMID 24370890
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of human pluripotent stem cells (hPSCs) to differentiate into any cell type of the three germ layers makes them a very promising cell source for multiple purposes, including regenerative medicine, drug discovery, and as a model to study disease mechanisms and progression. One of the first specialized cell types to be generated from hPSC was cardiomyocytes (CM), and differentiation protocols have evolved over the years and now allow for robust and large-scale production of hPSC-CM. Still, scientists are struggling to achieve the same, mainly ventricular, phenotype of the hPSC-CM in vitro as their adult counterpart in vivo. In vitro generated cardiomyocytes are generally described as fetal-like rather than adult. In this review, we compare the in vivo development of cardiomyocytes to the in vitro differentiation of hPSC into CM with focus on electrophysiology, structure and contractility. Furthermore, known epigenetic changes underlying the differences between adult human CM and CM differentiated from pluripotent stem cells are described. This should provide the reader with an extensive overview of the current status of human stem cell-derived cardiomyocyte phenotype and function. Additionally, the reader will gain insight into the underlying signaling pathways and mechanisms responsible for cardiomyocyte development.

Citing Articles

Detection of biomagnetic signals from induced pluripotent stem cell-derived cardiomyocytes using deep learning with simulation data.

Yamaguchi T, Adachi Y, Tanida T, Taguchi K, Oka Y, Yoshida T Sci Rep. 2024; 14(1):7296.

PMID: 38538741 PMC: 10973465. DOI: 10.1038/s41598-024-58010-0.


Biomimetic Approaches in Cardiac Tissue Engineering: Replicating the Native Heart Microenvironment.

Khan A, Kumari P, Kumari N, Shaikh U, Ekhator C, Halappa Nagaraj R Cureus. 2023; 15(8):e43431.

PMID: 37581196 PMC: 10423641. DOI: 10.7759/cureus.43431.


Advances in Manufacturing Cardiomyocytes from Human Pluripotent Stem Cells.

Floy M, Shabnam F, Simmons A, Bhute V, Jin G, Friedrich W Annu Rev Chem Biomol Eng. 2022; 13:255-278.

PMID: 35320695 PMC: 9197878. DOI: 10.1146/annurev-chembioeng-092120-033922.


Therapeutic Ultrasound Effects on Human Induced Pluripotent Stem Cell Cardiomyocytes Measured Optically and with Spectral Ultrasound.

Chen A, Saab G, Jeremic A, Zderic V Ultrasound Med Biol. 2022; 48(6):1078-1094.

PMID: 35304006 PMC: 9179027. DOI: 10.1016/j.ultrasmedbio.2022.02.006.


Myosin light chain 2 marks differentiating ventricular cardiomyocytes derived from human embryonic stem cells.

Luo X, Zhang P, Liu X, Huang S, Rao S, Ding Q Pflugers Arch. 2021; 473(7):991-1007.

PMID: 34031754 DOI: 10.1007/s00424-021-02578-3.